Plain-English translation of NCT07035093 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a medication called to see if it can help relieve chronic low back pain in people who are overweight or have obesity. The medication is given as a weekly injection under the skin. Researchers want to understand whether this treatment is safe and effective for reducing back pain in this group of patients.
Many people with excess weight experience chronic low back pain, and current treatment options are limited. This study explores whether this medication—which may help with both weight and pain—could offer a new treatment option for people struggling with this combination of conditions.
Over about 80 weeks, you will visit the study clinic regularly to receive either the new medication or a placebo (inactive treatment) as a weekly injection. You will be randomly assigned to one of these two groups, and neither you nor the researchers will know which one you're receiving. During visits, the study team will check how your back pain and weight are changing, and monitor your health and safety.
AI-generated summary from trial data · Aug 3, 2026 · Not medical advice
United States